(Q34120068)

31 July 2017

1 reference

title

Non-stimulant treatments for ADHD. (English)

1 reference

31 July 2017

1

Biederman J

1 reference

31 July 2017

Spencer T

2

1 reference

31 July 2017

1 January 2000

1 reference

European Child & Adolescent Psychiatry

31 July 2017

1 reference

31 July 2017

9 Suppl 1

1 reference

31 July 2017

I51-9

1 reference

https://scigraph.springernature.com/pub.10.1007/s007870070019

31 July 2017

0 references

cites work

A review of stimulant drug research with hyperactive children

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

A pilot study of nadolol for overt aggression in developmentally delayed individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Response of children with ADHD to methylphenidate: interaction with internalizing symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Is attention deficit hyperactivity disorder familial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Risperidone treatment for juvenile bipolar disorder: a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS007870070019

21 January 2018

12 December 2020

Hyperactive boys almost grown up. I. Psychiatric status

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Genetic factors in hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

A twin study of hyperactivity--I. An examination of hyperactivity scores and categories derived from Rutter teacher and parent questionnaires.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Imipramine in the Treatment of Minimal Brain Dysfunction in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Nicotine effects on adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

An open clinical trial of buspirone in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Hyperactive boys almost grown up. V. Replication of psychiatric status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: Issues of gene-environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: comparative effects upon vigilance and heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Attention, memory, and cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Effect of anxiety on cognition, behavior, and stimulant response in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

One-year follow-up of hyperactive boys treated with imipramine or methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Imipramine and methylphenidate treatments of hyperactive boys. A double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

The Personality Inventory for Children and response to methylphenidate: preliminary evidence for predictive utility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Nortriptyline in the treatment of ADHD: a chart review of 58 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Effects of Imipramine and Dextroamphetamine on Behavior of Neuropsychiatrically Impaired Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Amitriptyline and methylphenidate treatment of behaviorally disordered children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070019

Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H.

21 January 2018

1 reference

12 December 2020

Combination of treatments for attention deficit hyperactivity disorder in adults.

1 reference

12 December 2020

Propranolol for adults with temper outbursts and residual attention deficit disorder.

1 reference

12 December 2020

A double-blind trial of bupropion in children with attention deficit disorder

1 reference

12 December 2020

The effects of cigarettes of varying yield on rapid information processing performance

1 reference

12 December 2020

Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples

1 reference

12 December 2020

Bupropion in children with attention deficit disorder.

1 reference

12 December 2020

Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome

1 reference

12 December 2020

Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder.

1 reference

12 December 2020

Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings

1 reference

12 December 2020

Behavioral effects of prenatal exposure to nicotine in guinea pigs.

1 reference

12 December 2020

Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder

1 reference

12 December 2020

A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine

1 reference

12 December 2020

Modification of hyperkinetic behavior by nortriptyline

1 reference

12 December 2020

A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder

1 reference

12 December 2020

Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Effectiveness and tolerance of the selective MAO-A inhibitor moclobemide in children with hyperkinetic syndrome

1 reference

12 December 2020

Postnatal behavioural effects of maternal nicotine exposure in rats

1 reference

12 December 2020

Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects

1 reference

12 December 2020

An indication for use of imipramine in attention deficit disorder

1 reference

12 December 2020

Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour

1 reference

12 December 2020

Bupropion treatment of attention-deficit hyperactivity disorder in adults

1 reference

12 December 2020

Cholinergic modulation of the content of temporal memory

1 reference

12 December 2020

Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder

1 reference

12 December 2020

Imipramine and methylphenidate in hyperactive children

1 reference

12 December 2020

A naturalistic assessment of protriptyline for attention-deficit hyperactivity disorder

1 reference

12 December 2020

Desipramine in the treatment of attention deficit disorder in adolescents

1 reference

12 December 2020

An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Motor performance in hyperactive children treated with imipramine

1 reference

12 December 2020

A twin study of hyperactivity--II. The aetiological role of genes, family relationships and perinatal adversity

1 reference

12 December 2020

ADHD is associated with early initiation of cigarette smoking in children and adolescents

1 reference

12 December 2020

A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder

1 reference

12 December 2020

Alcohol abuse and attention deficit disorder

1 reference

12 December 2020

Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial

1 reference

12 December 2020

Genetic latent structure analysis of dysmorphology in attention deficit disorder

1 reference

12 December 2020

Combining methylphenidate and clonidine: a clinically sound medication option

1 reference

12 December 2020

Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children

1 reference

12 December 2020

Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity

1 reference

12 December 2020

Treatment of ADHD with fluoxetine: a preliminary trial.

1 reference

12 December 2020

Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience

1 reference

12 December 2020

Alterations in the vigilance performance of children receiving amitriptyline and methylphenidate pharmacotherapy

1 reference

12 December 2020

The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.

1 reference

12 December 2020

A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response

1 reference

12 December 2020

The use of imipramine in children's behavior disorders

1 reference

12 December 2020

A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine

1 reference

12 December 2020

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

1 reference

12 December 2020

Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor

1 reference

12 December 2020

Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children?

1 reference

12 December 2020

Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder

1 reference

12 December 2020

Desipramine in the treatment of children with attention deficit disorder

1 reference

12 December 2020

The use of imipramine in Tourette's syndrome and attention deficit disorder: case report

1 reference

12 December 2020

Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems

1 reference

12 December 2020

Identifiers

DOI

10.1007/S007870070019

1 reference

release_fh52ofw2grghjfop4skvi75o5a

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fh52ofw2grghjfop4skvi75o5a

24 November 2022

mapped directly with Wikidata item

PubMed ID

11140780

1 reference

PubMed ID

11140780